Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
TripSitter Clinic Ltd ( (TSE:KETA) ) just unveiled an update.
TripSitter Clinic Ltd. has reached agreements with certain creditors to settle $292,311.48 in outstanding liabilities by issuing 4,102,616 common shares at a deemed price of $0.07125 per share, converting debt into equity. The share-based debt settlement, which remains subject to Canadian Securities Exchange approval and includes a four-month-and-one-day hold period, is expected to improve the company’s balance sheet and ease immediate cash obligations, with implications for existing shareholder dilution and future financing flexibility.
The most recent analyst rating on (TSE:KETA) stock is a Sell with a C$0.06 price target. To see the full list of analyst forecasts on TripSitter Clinic Ltd stock, see the TSE:KETA Stock Forecast page.
Spark’s Take on KETA Stock
According to Spark, TipRanks’ AI Analyst, KETA is a Underperform.
The score is driven primarily by very weak financial performance (near-zero revenue, ongoing losses, negative equity, and continued cash burn), which outweighs any near-term technical oversold signals. Valuation is also unattractive/unclear due to negative earnings and no dividend support.
To see Spark’s full report on KETA stock, click here.
More about TripSitter Clinic Ltd
TripSitter Clinic Ltd. is a Canadian healthcare company listed on the CSE under the symbol KETA, focused on providing clinic-based services, likely within the emerging therapeutic and wellness segment. Operating from Toronto and Vancouver, the company serves patients through specialized clinical offerings in a regulated medical environment.
Average Trading Volume: 37,947
Technical Sentiment Signal: Buy
Current Market Cap: C$632.5K
See more insights into KETA stock on TipRanks’ Stock Analysis page.